Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Whipple's disease

C Ramaiah¹, R F Boynton

¹Division of Gastroenterology and Hepatology, Allegheny University of the Health Sciences, Philadelphia, Pennsylvania, USA.

Gastroenterology Clinics of North America

|January 19, 1999

Summary

Whipple's disease, a chronic infection by Tropheryma whippelii, is now better understood and treatable. Advances in immunology, diagnostics, and therapy offer improved outcomes for this formerly fatal condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluation and treatment of chronic hepatitis C infection.

Primary care·1996

Same author

Re: Watemberg et al., Signs and symptoms of cholelithiasis.

The American journal of gastroenterology·1996

Same author

Regional levels of lactate and norepinephrine after experimental brain injury.

Journal of neurochemistry·1994

Same author

Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.

Cancer research·1993

Same author

Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers.

Cancer research·1992

Same author

Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers.

Proceedings of the National Academy of Sciences of the United States of America·1992

Area of Science:

Infectious Diseases
Microbiology
Immunology

Background:

Whipple's disease is a chronic, multisystem infectious condition.
It is caused by the bacterium Tropheryma whippelii.
Historically, it was considered a uniformly fatal disease.

Observation:

Recent advancements have shed light on this unusual infectious process.
Significant progress has been made in understanding the disease's pathogenesis and clinical manifestations.

Findings:

The article reviews key advancements in the immunologic aspects of Whipple's disease.
Diagnostic innovations have improved the identification of Tropheryma whippelii infections.
Therapeutic strategies have evolved, leading to better patient outcomes.

Implications:

Future research in basic and clinical sciences is expected to accelerate diagnosis.
A more comprehensive understanding of infection effects will be achieved.
Improved therapies and clinical outcomes are anticipated for patients with Whipple's disease.

Related Experiment Videos